Sector
PharmaceuticalsOpen
₹150.6Prev. Close
₹150.62Turnover(Lac.)
₹3,579.52Day's High
₹158.27Day's Low
₹15052 Week's High
₹25852 Week's Low
₹109.3Book Value
₹-6.79Face Value
₹1Mkt Cap (₹ Cr.)
5,084.28P/E
0EPS
0Divi. Yield
012 May 2025
12:00 AM
Board Meeting
Agenda : Audited Result
8 Jul 2024
12:00 AM
AGM
Announcement Date: 08 Jul, 2024
At the operating level, the EBITDA loss amounted to ₹102.9 Crore, a worsening from a loss of ₹91.4 Crore in the previous fiscal quarter.
| Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|
Equity Capital | 32.45 | 32.45 | 261.45 | 26.21 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 92.4 | 480.32 | -230.22 | -194.46 |
Net Worth | 124.85 | 512.77 | 31.23 | -168.25 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 252.95 | 76.81 | 78.25 | 181.02 |
yoy growth (%) | 229.3 | -1.84 | -56.76 | 12.24 |
Raw materials | -18.17 | -23.92 | -26.8 | -25.16 |
As % of sales | 7.18 | 31.14 | 34.25 | 13.89 |
Employee costs | -91.58 | -93.08 | -100.92 | -84.3 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -151.13 | -312.4 | -245.97 | -119.03 |
Depreciation | -10.92 | -9.48 | -8.18 | -8.23 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 59.11 | -68.31 | -89.36 | 46.78 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 229.3 | -1.84 | -56.76 | 12.24 |
Op profit growth | -56.46 | 27.78 | 97.72 | 94.16 |
EBIT growth | -54.64 | 25.98 | 109.73 | 72.79 |
Net profit growth | -51.62 | 58.58 | 65.49 | 70.07 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 |
|---|---|---|---|
Gross Sales | 71.77 | 75.55 | 238.78 |
Excise Duty | 0 | 0 | 0 |
Net Sales | 71.77 | 75.55 | 238.78 |
Other Operating Income | 0 | 0 | 0 |
Other Income | 1.79 | 29.47 | 10.88 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,647.6 | 92.29 | 3,95,254.45 | 2,000.46 | 0.97 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,493 | 78.03 | 1,72,374.06 | 667 | 0.46 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,484 | 24.33 | 1,19,795.19 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Dr Reddys Laboratories Ltd DRREDDY | 1,326.1 | 20.69 | 1,10,689.83 | 1,200.7 | 0.6 | 5,546.3 | 345.79 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,164 | 56.27 | 1,07,213.01 | 474 | 1.01 | 2,385 | 224.33 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
T Rajamannar
Non Executive Director
Sudhir V Valia
Independent Director
Bhavna Doshi
Independent Director
Ferzaan Engineer
Independent Director
Robert Spiegel
Chairman (Non-Executive)
Dilip S Shanghvi
Company Sec. & Compli. Officer
Kajal Damania.
Non Executive Director
Vidhi Shanghvi
Additional Director
Rekha Gopal Warriar
Additional Director
Venkateswarlu Jasti
Sun Pharma Advanced Res Centre,
Akota Road Akota,
Gujarat - 390020
Tel: 91-265-2330815/2339257
Website: http://www.sparc.life
Email: secretarial@sparcmail.com
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: www.linkintime.co.in
Email: paytm.ipo@linkintime.co.in
Summary
Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems. The Company works on innovation and new product ...
Read More
Reports by Sun Pharma Advanced Research Company Ltd
What is the Sun Pharma Advanced Research Company Ltd share price today?
What is the Market Cap of Sun Pharma Advanced Research Company Ltd?
What is the PE and PB ratio of Sun Pharma Advanced Research Company Ltd?
What is the 52 Week High and Low of Sun Pharma Advanced Research Company Ltd?
What is the CAGR of Sun Pharma Advanced Research Company Ltd?
What is the shareholding pattern of Sun Pharma Advanced Research Company Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
